Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Deep phenotyping of 34,128 patients hospitalised with COVID-19 and a comparison with 81,596 influenza patients in America, Europe and Asia: an international network study

View ORCID ProfileEdward Burn, Seng Chan You, Anthony G. Sena, Kristin Kostka, Hamed Abedtash, Maria Tereza F. Abrahão, Amanda Alberga, Heba Alghoul, Osaid Alser, Thamir M Alshammari, Maria Aragon, Carlos Areia, Juan M. Banda, Jaehyeong Cho, Aedin C Culhane, Alexander Davydov, Frank J DeFalco, Talita Duarte-Salles, Scott DuVall, Thomas Falconer, Sergio Fernandez-Bertolin, Weihua Gao, Asieh Golozar, Jill Hardin, George Hripcsak, Vojtech Huser, Hokyun Jeon, Yonghua Jing, Chi Young Jung, Benjamin Skov Kaas-Hansen, Denys Kaduk, Seamus Kent, Yeesuk Kim, Spyros Kolovos, Jennifer C.E. Lane, Hyejin Lee, Kristine E Lynch, Rupa Makadia, Michael E. Matheny, Paras P. Mehta, Daniel R Morales, Karthik Natarajan, Fredrik Nyberg, Anna Ostropolets, Rae Woong Park, Jimyung Park, Jose D. Posada, Albert Prats-Uribe, Gowtham Rao, Christian Reich, Yeunsook Rho, Peter Rijnbeek, Lisa M. Schilling, Martijn Schuemie, Nigam H. Shah, Azza Shoaibi, Seokyoung Song, Matthew Spotnitz, Marc A. Suchard, Joel N. Swerdel, David Vizcaya, Salvatore Volpe, Haini Wen, Andrew E. Williams, Belay B. Yimer, Lin Zhang, Oleg Zhuk, Daniel Prieto-Alhambra, Patrick Ryan
doi: https://doi.org/10.1101/2020.04.22.20074336
Edward Burn
1Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain
2Centre for Statistics in Medicine (CSM), Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDROMS), University of Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Edward Burn
Seng Chan You
3Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anthony G. Sena
4Janssen Research and Development, Titusville, NJ, US
5Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristin Kostka
6Real World Solutions, IQVIA, Cambridge, MA, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hamed Abedtash
7Eli Lilly and Company, Indianapolis, IN, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Tereza F. Abrahão
8Faculty of Medicine, University of Sao Paulo, Sao Paulo, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amanda Alberga
9Observational Health Data Sciences and Informatics Network, Alberta, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heba Alghoul
10Faculty of Medicine, Islamic University of Gaza, Palestine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Osaid Alser
11Massachusetts General Hospital, Harvard Medical School, Boston, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thamir M Alshammari
12Medication Safety Research Chair, King Saud University, Saudi Arabia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Aragon
1Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlos Areia
13Nuffield Department of Clinical Neurosciences, University of Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juan M. Banda
14Department of Computer Science, Georgia State University, Atlanta, GA, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jaehyeong Cho
3Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aedin C Culhane
15Data Science, Dana-Farber Cancer Institute. Biostatistics, Harvard TH Chan School of Public Health, Boston, MA, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander Davydov
16Odysseus Data Services, Inc., MA, Cambridge, US
17Department for Microbiology, Virology and Immunology, Belarusian State Medical University, Minsk, Belarus
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank J DeFalco
4Janssen Research and Development, Titusville, NJ, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Talita Duarte-Salles
1Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott DuVall
18Department of Veterans Affairs, Salt Lake City, UT, US
19University of Utah School of Medicine, Salt Lake City, UT, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Falconer
20Department of Biomedical Informatics, Columbia University, New York, NY, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sergio Fernandez-Bertolin
1Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Weihua Gao
21Health Economics and Outcomes Research, AbbVie, North Chicago, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Asieh Golozar
22Pharmacoepidemiology, Regeneron, NY, US
23Department of Epidemiology, Johns Hopkins School of Public, Baltimore, MD, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jill Hardin
4Janssen Research and Development, Titusville, NJ, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George Hripcsak
20Department of Biomedical Informatics, Columbia University, New York, NY, US
24New York-Presbyterian Hospital, New York, NY, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vojtech Huser
25National Library of Medicine, National Institutes of Health, MD, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hokyun Jeon
26Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yonghua Jing
21Health Economics and Outcomes Research, AbbVie, North Chicago, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chi Young Jung
27Division of respiratory and critical care medicine, Department of Internal medicine, Daegu Catholic University Medical Center, Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin Skov Kaas-Hansen
28Clinical Pharmacology Unit, Zealand University Hospital, Denmark
29NNF Centre for Protein Research, Unversity of Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Denys Kaduk
16Odysseus Data Services, Inc., MA, Cambridge, US
30Department of Pediatrics № 2, V. N. Karazin Kharkiv National University, Kharkiv, Ukraine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seamus Kent
31Science Policy and Research, National Institute for Health and Care Excellence, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yeesuk Kim
32Department of Orthopaedic Surgery, College of Medicine, Hanyang University, Seoul, Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Spyros Kolovos
33Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDROMS), University of Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer C.E. Lane
33Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDROMS), University of Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hyejin Lee
34Bigdata Department, Health Insurance Review & Assessment Service, Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristine E Lynch
18Department of Veterans Affairs, Salt Lake City, UT, US
19University of Utah School of Medicine, Salt Lake City, UT, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rupa Makadia
4Janssen Research and Development, Titusville, NJ, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael E. Matheny
35GRECC, Tennessee Valley Healthcare System VA, Nashville, US
36Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paras P. Mehta
37College of Medicine-Tucson, University of Arizona, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel R Morales
38Division of Population Health and Genomics, University of Dundee, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karthik Natarajan
20Department of Biomedical Informatics, Columbia University, New York, NY, US
24New York-Presbyterian Hospital, New York, NY, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fredrik Nyberg
39School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Ostropolets
20Department of Biomedical Informatics, Columbia University, New York, NY, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rae Woong Park
3Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Korea
26Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jimyung Park
26Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jose D. Posada
40Department of Medicine, School of Medicine, Stanford University, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Albert Prats-Uribe
2Centre for Statistics in Medicine (CSM), Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDROMS), University of Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gowtham Rao
4Janssen Research and Development, Titusville, NJ, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian Reich
6Real World Solutions, IQVIA, Cambridge, MA, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yeunsook Rho
33Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDROMS), University of Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Rijnbeek
5Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lisa M. Schilling
41Data Science to Patient Value Program, Department of Medicine, University of Colorado Anschutz Medical Campus, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martijn Schuemie
4Janssen Research and Development, Titusville, NJ, US
42Department of Biostatistics, UCLA Fielding School of Public Health, University of California, Los Angeles, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nigam H. Shah
40Department of Medicine, School of Medicine, Stanford University, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Azza Shoaibi
4Janssen Research and Development, Titusville, NJ, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seokyoung Song
43Department of Anesthesiology and Pain Medicine, Catholic University of Daegu, School of medicine, Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Spotnitz
20Department of Biomedical Informatics, Columbia University, New York, NY, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc A. Suchard
42Department of Biostatistics, UCLA Fielding School of Public Health, University of California, Los Angeles, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joel N. Swerdel
4Janssen Research and Development, Titusville, NJ, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Vizcaya
44Bayer Pharmaceuticals, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Salvatore Volpe
20Department of Biomedical Informatics, Columbia University, New York, NY, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Haini Wen
45Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew E. Williams
46Tufts Institute for Clinical Research and Health Policy Studies, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Belay B. Yimer
47Centre for Epidemiology Versus Arthritis, Manchester Academic Health Science Centre, The University of Manchester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lin Zhang
48School of Public Health, Peking Union Medical College, Chinese Academy of Medical Sciences, China
49Melbourne School of Population and Global Health, The University of Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oleg Zhuk
16Odysseus Data Services, Inc., MA, Cambridge, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Prieto-Alhambra
2Centre for Statistics in Medicine (CSM), Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDROMS), University of Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: daniel.prietoalhambra{at}ndorms.ox.ac.uk
Patrick Ryan
4Janssen Research and Development, Titusville, NJ, US
50Columbia University, New York, NY, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background In this study we phenotyped individuals hospitalised with coronavirus disease 2019 (COVID-19) in depth, summarising entire medical histories, including medications, as captured in routinely collected data drawn from databases across three continents. We then compared individuals hospitalised with COVID-19 to those previously hospitalised with influenza.

Methods We report demographics, previously recorded conditions and medication use of patients hospitalised with COVID-19 in the US (Columbia University Irving Medical Center [CUIMC], Premier Healthcare Database [PHD], UCHealth System Health Data Compass Database [UC HDC], and the Department of Veterans Affairs [VA OMOP]), in South Korea (Health Insurance Review & Assessment [HIRA]), and Spain (The Information System for Research in Primary Care [SIDIAP] and HM Hospitales [HM]). These patients were then compared with patients hospitalised with influenza in 2014-19.

Results 34,128 (US: 8,362, South Korea: 7,341, Spain: 18,425) individuals hospitalised with COVID-19 were included. Between 4,811 (HM) and 11,643 (CUIMC) unique aggregate characteristics were extracted per patient, with all summarised in an accompanying interactive website (http://evidence.ohdsi.org/Covid19CharacterizationHospitalization/). Patients were majority male in the US (CUIMC: 52%, PHD: 52%, UC HDC: 54%, VA OMOP: 94%,) and Spain (SIDIAP: 54%, HM: 60%), but were predominantly female in South Korea (HIRA: 60%). Age profiles varied across data sources. Prevalence of asthma ranged from 4% to 15%, diabetes from 13% to 43%, and hypertensive disorder from 24% to 70% across data sources. Between 14% and 33% were taking drugs acting on the renin-angiotensin system in the 30 days prior to hospitalisation. Compared to 81,596 individuals hospitalised with influenza in 2014-19, patients admitted with COVID-19 were more typically male, younger, and healthier, with fewer comorbidities and lower medication use.

Conclusions We provide a detailed characterisation of patients hospitalised with COVID-19. Protecting groups known to be vulnerable to influenza is a useful starting point to minimize the number of hospital admissions needed for COVID-19. However, such strategies will also likely need to be broadened so as to reflect the particular characteristics of individuals hospitalised with COVID-19.

Competing Interest Statement

All authors have completed the ICMJE uniform disclosure form, with the following declarations made: DPA reports grants and other from AMGEN, grants, non-financial support and other from UCB Biopharma, grants from Les Laboratoires Servier, outside the submitted work; and Janssen, on behalf of IMI-funded EHDEN and EMIF consortiums, and Synapse Management Partners have supported training programmes organised by DPA's department and open for external participants. DV reports personal fees from Bayer, outside the submitted work; and he is a full-time employee at a pharmaceutical company. DM reports funding support from the Wellcome Trust, NIHR, Scottish CSO and Tenovus Scotland for research unrelated to this work. SCY reports grants from Korean Ministry of Health & Welfare, grants from Korean Ministry of Trade, Industry & Energy, during the conduct of the study. AG reports personal fees from Regeneron Pharmaceuticals, outside the submitted work; and she a full-time employee at Regeneron Pharmaceuticals. This work was not conducted at Regeneron Pharmaceuticals. YJ reports employee of AbbVie and own company stock. AA reports: I am currently employed at Alberta Health Services (AHS) as a Data Science Lead redeployed as an epidemiologist to aid in the COVID-19 response. This work was not conducted at AHS, within AHS working hours, or with AHS staff. I contributed and conducted this work as an Independent Epidemiologist, as a member of the Observational Health Data Sciences and Informatics (OHDSI) Network. PR reports grants from Innovative Medicines Initiative, grants from Janssen Research and Development, during the conduct of the study. MS reports grants from US National Science Foundation, grants from US National Institutes of Health, grants from IQVIA, personal fees from Janssen Research and Development, during the conduct of the study. GH reports grants from US NIH National Library of Medicine, during the conduct of the study; grants from Janssen Research, outside the submitted work. APU reports grants from Fundacion Alfonso Martin Escudero, grants from Medical Research Council, outside the submitted work. HA reports personal fees from Eli Lilly and Company, outside the submitted work. AS reports personal fees from Janssen Research & Development, during the conduct of the study; personal fees from Janssen Research & Development, outside the submitted work. AS is a full time employee of Janssen and shareholder of Johnson & Johnson. GR is a full time employee of Janssen and shareholder of Johnson & Johnson. FD reports personal fees from Janssen Research & Development, during the conduct of the study; personal fees from Janssen Research & Development, outside the submitted work. RWP reports grants from Korean Ministry of Health & Welfare, grants from Korean Ministry of Trade, Industry & Energy, during the conduct of the study. JP reports grants from Korean Ministry of Health & Welfare, grants from Korean Ministry of Trade, Industry & Energy, during the conduct of the study. JC reports grants from Korean Ministry of Health & Welfare, grants from Korean Ministry of Trade, Industry & Energy, during the conduct of the study. SD reports grants from Anolinx, LLC, grants from Astellas Pharma, Inc, grants from AstraZeneca Pharmaceuticals LP, grants from Boehringer Ingelheim International GmbH, grants from Celgene Corporation, grants from Eli Lilly and Company, grants from Genentech Inc.,, grants from Genomic Health, Inc., grants from Gilead Sciences Inc., grants from GlaxoSmithKline PLC, grants from Innocrin Pharmaceuticals Inc., grants from Janssen Pharmaceuticals, Inc., grants from Kantar Health, grants from Myriad Genetic Laboratories, Inc., grants from Novartis International AG, grants from Parexel International Corporation through the University of Utah or Western Institute for Biomedical Research outside the submitted work. HJ reports grants from Korean Ministry of Health & Welfare, grants from Korean Ministry of Trade, Industry & Energy, during the conduct of the study. BSKH reports grants from Innovation Fund Denmark (5153-00002B) and the Novo Nordisk Foundation (NNF14CC0001), outside the submitted work. KK reports she is an employee of IQVIA. CR reports he is an employee of IQVIA. JS reports other from Janssen R&D, during the conduct of the study; other from Janssen R&D, outside the submitted work; and JS was a full-time employee of Johnson & Johnson, or a subsidiary, at the time the study was conducted. JS owns stock, stock options, and pension rights from the company. RM reports and is employee of Janssen Research and Development. WG is an AbbVie employee. PR reports and is employee of Janssen Research and Development and shareholder of Johnson & Johnson. MS is a full-time employee of Janssen R&D, and a shareholder of Johnson & Johnson. JH reports other from Janssen Research & Development, during the conduct of the study; other from Janssen Research & Development, outside the submitted work; and full time employee of Janssen and shareholder of Johnson & Johnson.

Funding Statement

This project has received support from the European Health Data and Evidence Network (EHDEN) project. EHDEN has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 806968. The JU receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA. This research received partial support from the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), US National Institutes of Health, US Department of Veterans Affairs, Janssen Research & Development, and IQVIA. This work was also supported by the Bio Industrial Strategic Technology Development Program (20001234) funded by the Ministry of Trade, Industry & Energy (MOTIE, Korea) and a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea [grant number: HI16C0992]. Personal funding included Versus Arthritis [21605], Medical Research Council Doctoral Training Partnership (MRC-DTP) [MR/K501256/1] (JL); Medical Research Council (MRC) and Fundación Alfonso Martín Escudero (FAME) (APU); Innovation Fund Denmark (5153-00002B) and the Novo Nordisk Foundation (NNF14CC0001) (BSKH); VINCI [VA HSR RES 13-457] (SLD, MEM, KEL); NIHR Senior Research Fellowship (SRF-2018-11-ST2-004, DPA); Bill & Melinda Gates Foundation (INV-016201); the Intramural Research Program of the National Institutes of Health / National Library of Medicine / Lister Hill National Center for Biomedical Communications (VH); and the Direcció General de Recerca i Innovació en Salut from the Department of Health of the Generalitat de Catalunya. No funders had a direct role in this study. The views and opinions expressed are those of the authors and do not necessarily reflect those of the Clinician Scientist Award programme, NIHR, Department of Veterans Affairs or the United States Government, NHS or the Department of Health, England.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All the data partners received Institutional Review Board (IRB) approval or exemption. STARR-OMOP had approval from IRB Panel #8 (RB-53248) registered to Leland Stanford Junior University under the Stanford Human Research Protection Program (HRPP). The use of VA data was reviewed by the Department of Veterans Affairs Central Institutional Review Board (IRB) and was determined to meet the criteria for exemption under Exemption Category 4(3) and approved the request for Waiver of HIPAA Authorization. The research was approved by the Columbia University Institutional Review Board as an OHDSI network study. The IRB number for use of HIRA data was AJIB-MED-EXP-20-065. HM Hospitales and SIDIAP analyses were approved by the Clinical Research Ethics Committee of the IDIAPJGol (project code: 20/070-PCV). The UC-HDC data use was reviewed by Colorado Multi-Institutional Review Board (COMIRB) and was determined to meet the criteria for exemption under Exemption Category 4(3) and approved the request for Waiver of HIPAA Authorization (protocol # 20-0730).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Open Science is a guiding principle within OHDSI. As such, we provide unfettered access to all open-source analysis tools employed in this study via https://github.com/OHDSI/, as well as all data and results artefacts that do not include patient-level health information via http://evidence.ohdsi.org/Covid19CharacterizationHospitalization/. Data partners contributing to this study remain custodians of their individual patient-level health information and hold either IRB exemption or approval for participation.

http://evidence.ohdsi.org/Covid19CharacterizationHospitalization/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted June 28, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Deep phenotyping of 34,128 patients hospitalised with COVID-19 and a comparison with 81,596 influenza patients in America, Europe and Asia: an international network study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Deep phenotyping of 34,128 patients hospitalised with COVID-19 and a comparison with 81,596 influenza patients in America, Europe and Asia: an international network study
Edward Burn, Seng Chan You, Anthony G. Sena, Kristin Kostka, Hamed Abedtash, Maria Tereza F. Abrahão, Amanda Alberga, Heba Alghoul, Osaid Alser, Thamir M Alshammari, Maria Aragon, Carlos Areia, Juan M. Banda, Jaehyeong Cho, Aedin C Culhane, Alexander Davydov, Frank J DeFalco, Talita Duarte-Salles, Scott DuVall, Thomas Falconer, Sergio Fernandez-Bertolin, Weihua Gao, Asieh Golozar, Jill Hardin, George Hripcsak, Vojtech Huser, Hokyun Jeon, Yonghua Jing, Chi Young Jung, Benjamin Skov Kaas-Hansen, Denys Kaduk, Seamus Kent, Yeesuk Kim, Spyros Kolovos, Jennifer C.E. Lane, Hyejin Lee, Kristine E Lynch, Rupa Makadia, Michael E. Matheny, Paras P. Mehta, Daniel R Morales, Karthik Natarajan, Fredrik Nyberg, Anna Ostropolets, Rae Woong Park, Jimyung Park, Jose D. Posada, Albert Prats-Uribe, Gowtham Rao, Christian Reich, Yeunsook Rho, Peter Rijnbeek, Lisa M. Schilling, Martijn Schuemie, Nigam H. Shah, Azza Shoaibi, Seokyoung Song, Matthew Spotnitz, Marc A. Suchard, Joel N. Swerdel, David Vizcaya, Salvatore Volpe, Haini Wen, Andrew E. Williams, Belay B. Yimer, Lin Zhang, Oleg Zhuk, Daniel Prieto-Alhambra, Patrick Ryan
medRxiv 2020.04.22.20074336; doi: https://doi.org/10.1101/2020.04.22.20074336
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Deep phenotyping of 34,128 patients hospitalised with COVID-19 and a comparison with 81,596 influenza patients in America, Europe and Asia: an international network study
Edward Burn, Seng Chan You, Anthony G. Sena, Kristin Kostka, Hamed Abedtash, Maria Tereza F. Abrahão, Amanda Alberga, Heba Alghoul, Osaid Alser, Thamir M Alshammari, Maria Aragon, Carlos Areia, Juan M. Banda, Jaehyeong Cho, Aedin C Culhane, Alexander Davydov, Frank J DeFalco, Talita Duarte-Salles, Scott DuVall, Thomas Falconer, Sergio Fernandez-Bertolin, Weihua Gao, Asieh Golozar, Jill Hardin, George Hripcsak, Vojtech Huser, Hokyun Jeon, Yonghua Jing, Chi Young Jung, Benjamin Skov Kaas-Hansen, Denys Kaduk, Seamus Kent, Yeesuk Kim, Spyros Kolovos, Jennifer C.E. Lane, Hyejin Lee, Kristine E Lynch, Rupa Makadia, Michael E. Matheny, Paras P. Mehta, Daniel R Morales, Karthik Natarajan, Fredrik Nyberg, Anna Ostropolets, Rae Woong Park, Jimyung Park, Jose D. Posada, Albert Prats-Uribe, Gowtham Rao, Christian Reich, Yeunsook Rho, Peter Rijnbeek, Lisa M. Schilling, Martijn Schuemie, Nigam H. Shah, Azza Shoaibi, Seokyoung Song, Matthew Spotnitz, Marc A. Suchard, Joel N. Swerdel, David Vizcaya, Salvatore Volpe, Haini Wen, Andrew E. Williams, Belay B. Yimer, Lin Zhang, Oleg Zhuk, Daniel Prieto-Alhambra, Patrick Ryan
medRxiv 2020.04.22.20074336; doi: https://doi.org/10.1101/2020.04.22.20074336

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (434)
  • Allergy and Immunology (760)
  • Anesthesia (222)
  • Cardiovascular Medicine (3316)
  • Dentistry and Oral Medicine (366)
  • Dermatology (282)
  • Emergency Medicine (480)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1175)
  • Epidemiology (13403)
  • Forensic Medicine (19)
  • Gastroenterology (900)
  • Genetic and Genomic Medicine (5182)
  • Geriatric Medicine (483)
  • Health Economics (786)
  • Health Informatics (3286)
  • Health Policy (1146)
  • Health Systems and Quality Improvement (1199)
  • Hematology (432)
  • HIV/AIDS (1024)
  • Infectious Diseases (except HIV/AIDS) (14657)
  • Intensive Care and Critical Care Medicine (917)
  • Medical Education (478)
  • Medical Ethics (128)
  • Nephrology (526)
  • Neurology (4957)
  • Nursing (263)
  • Nutrition (735)
  • Obstetrics and Gynecology (889)
  • Occupational and Environmental Health (797)
  • Oncology (2531)
  • Ophthalmology (730)
  • Orthopedics (284)
  • Otolaryngology (348)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (547)
  • Pediatrics (1308)
  • Pharmacology and Therapeutics (552)
  • Primary Care Research (559)
  • Psychiatry and Clinical Psychology (4225)
  • Public and Global Health (7526)
  • Radiology and Imaging (1717)
  • Rehabilitation Medicine and Physical Therapy (1022)
  • Respiratory Medicine (982)
  • Rheumatology (480)
  • Sexual and Reproductive Health (500)
  • Sports Medicine (425)
  • Surgery (551)
  • Toxicology (73)
  • Transplantation (237)
  • Urology (206)